Overview

Trial of Iressa in Prostate Cancer Patients

Status:
Completed

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

This study is being carried out to see if ZD1839 is effective in treating prostate cancer after being diagnosed with an early rising PSA (prostate specific antigen) following surgery.

Phase:

Phase 2

Details

Lead Sponsor:

AstraZeneca

Treatments:

Gefitinib